Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Khawaja M. Talha"'
Autor:
Muhammad Shahzeb Khan, MD, MSc, Khawaja M. Talha, MBBS, Muhammad Haisum Maqsood, MD, Jennifer A. Rymer, MD, MBA, Barry A. Borlaug, MD, Kieran F. Docherty, MD, Ambarish Pandey, MD, Florian Kahles, MD, Maja Cikes, MD, Carolyn S.P. Lam, MD, Anique Ducharme, MD, Adrian A. Voors, MD, Adrian F. Hernandez, MD, A. Michael Lincoff, MD, Mark C. Petrie, MD, Paul M. Ridker, MD, MPH, Marat Fudim, MD, MHS
Publikováno v:
JACC: Advances, Vol 3, Iss 8, Pp 101063- (2024)
Background: Elevated interleukin (IL)-6 levels have been linked to adverse outcomes in patients with and without baseline cardiovascular disease (CVD). Objectives: The purpose of this study was to examine the association between circulating IL-6 leve
Externí odkaz:
https://doaj.org/article/cd76b365474f441694530afc743a96f5
Autor:
Khawaja M. Talha, Talal Almas, Abdul Mannan Khan Minhas, Husam Salah, Adeena Jamil, Heather M. Johnson, Vardhmaan Jain, Steve Antoine, Sadiya S. Khan, Muhammad Shahzeb Khan
Publikováno v:
Therapeutic Advances in Cardiovascular Disease, Vol 18 (2024)
Background: The prevalence of heart failure (HF) is increasing among young adults in the United States with pervasive racial and ethnic differences in this population. Objective: To evaluate contemporary associations between race and ethnicity, clini
Externí odkaz:
https://doaj.org/article/dbaf8be3521649e9929bc8b146eb3a69
Autor:
Khawaja M. Talha, Ambarish Pandey, Marat Fudim, Javed Butler, Stefan D. Anker, Muhammad Shahzeb Khan
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 5, Pp 1959-1972 (2023)
Abstract At least half of all patients with heart failure (HF) are affected by frailty, a syndrome that limits an individual ability to recover from acute stressors. While frailty affects up to 90% of patients with HF with preserved ejection fraction
Externí odkaz:
https://doaj.org/article/83cf0e810e184639985f248de5e59751
Autor:
Michele Correale, Elena‐Laura Antohi, Riccardo M. Inciardi, Pietro Mazzeo, Stefano Coiro, Shiro Ishihara, Renata Petroni, Francesco Monitillo, Marta Leone, Marco Triggiani, Chaudhry M.S. Sarwar, Hans‐Dirk Dungen, Khawaja M. Talha, Natale D. Brunetti, Javed Butler, Savina Nodari, Master Program Group on Drug Development for Heart Failure
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 2066-2073 (2023)
Abstract Aims Sodium‐glucose cotransporter type 2 inhibitors (SGLT‐2i) represent a unique class of anti‐hyperglycaemic agents for type 2 diabetes mellitus that selectively inhibit renal glucose reabsorption, thereby increasing urinary excretion
Externí odkaz:
https://doaj.org/article/de59c9a117ce41d4beb61fc436b157b3
Autor:
Abdul Mannan Khan Minhas, MD, Khawaja M. Talha, MD, Michael Shapiro, MD, Vijay Nambi, MD, PhD, Salim S. Virani, MD, Anurag Mehta, MD, Dmitry Abramov, MD
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100542- (2023)
Therapeutic Area: ASCVD/CVD in Special Populations Background: Association between socioeconomic status and cardiovascular diseases (CVD) is well-documented. Racial disparities in prevalence and outcomes of CVD have also been extensively studied. The
Externí odkaz:
https://doaj.org/article/f97724f46e57420e882319e2d9509060
Autor:
Abdul Mannan Khan Minhas, MD, Khawaja M. Talha, MD, Michael Shapiro, MD, Vijay Nambi, MD, PhD, Salim S. Virani, MD, Anurag Mehta, MD, Dmitry Abramov, MD
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100559- (2023)
Therapeutic Area: ASCVD/CVD in Special Populations Background: Association between socioeconomic status and cardiovascular diseases (CVD) is well-documented. Racial disparities in prevalence and outcomes of CVD have also been extensively studied. The
Externí odkaz:
https://doaj.org/article/066703d855d349af8a0ca973bbbb747f
Autor:
Nandan S Anavekar, Christopher G Scott, Daniel C DeSimone, M Rizwan Sohail, Larry M Baddour, Khawaja M Talha, Kent R Bailey, Imad M Tleyjeh, Martin H Thornhill, Mark J Dayer, Raj Palraj, Verda Arshad, Wajeeha Tariq, Meredith C Hyun
Publikováno v:
Open Heart, Vol 8, Iss 2 (2021)
Externí odkaz:
https://doaj.org/article/fe01d4c22075412487b00d541fcb1d5a
Autor:
Muhammad Shahzeb Khan, Muhammad Shariq Usman, Khawaja M Talha, Harriette G C Van Spall, Stephen J Greene, Muthiah Vaduganathan, Sadiya S Khan, Nicholas L Mills, Ziad A Ali, Robert J Mentz, Gregg C Fonarow, Sunil V Rao, John A Spertus, Matthew T Roe, Stefan D Anker, Stefan K James, Javed Butler, Darren K McGuire
Publikováno v:
European Heart Journal. 44:1890-1909
Conventional randomized controlled trials (RCTs) can be expensive, time intensive, and complex to conduct. Trial recruitment, participation, and data collection can burden participants and research personnel. In the past two decades, there have been
Autor:
Khawaja M. Talha, Javed Butler, Stephen J. Greene, Rahul Aggarwal, Stefan D. Anker, Brian L. Claggett, Scott D. Solomon, John J. V. McMurray, Muthiah Vaduganathan, Gregg C. Fonarow
Publikováno v:
JAMA cardiology.
ImportanceThe expansion of sodium-glucose cotransporter-2 (SGLT-2) inhibitor use in patients with heart failure (HF) and left ventricular ejection fraction (LVEF) more than 40% following the EMPEROR-Preserved (Empagliflozin Outcome Trial in Patients
Autor:
Khawaja M, Talha, Stefan D, Anker, Daniel, Burkhoff, Gerasimos, Filippatos, Carolyn S P, Lam, Gregg W, Stone, Oussama, Wazni, Javed, Butler
Publikováno v:
Journal of Cardiac Failure. 28:1717-1726
Cardiac contractility modulation (also known as CCM) is a novel device therapy that delivers nonexcitatory electric stimulation to cardiac myocytes during the absolute refractory period, and it has been shown to improve functional status and clinical